WrapManager Inc’s Bicycle Therapeutics BCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,835
Closed -$388K 288
2022
Q1
$388K Sell
8,835
-231
-3% -$10.8K 0.1% 194
2021
Q4
$552K Sell
9,066
-554
-6% -$30.6K 0.14% 154
2021
Q3
$400K Sell
9,620
-46
-0.5% -$1.61K 0.1% 186
2021
Q2
$293K Buy
+9,666
New +$292K 0.08% 252

Other funds holding BCYC

WrapManager Inc's BCYC Position: Q2 2022 in Review

WrapManager Inc sold out of Bicycle Therapeutics (BCYC) in Q2 2022, closing a stake of 8,835 shares — an estimated $388K sold.

WrapManager Inc first reported a position in BCYC in Q2 2021 and held it in 4 quarters. The position peaked at $552K in Q4 2021. 81 funds tracked by Wall St. Rank hold BCYC as of Q2 2022.

  • WrapManager Inc reported no remaining Bicycle Therapeutics position as of Q2 2022 after selling out during the quarter.
  • WrapManager Inc sold 8,835 Bicycle Therapeutics shares in Q2 2022, an estimated $388K.
  • WrapManager Inc first reported a position in Bicycle Therapeutics in Q2 2021 and held it in 4 quarters.
  • WrapManager Inc's Bicycle Therapeutics position peaked at $552K in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2022.

Based on WrapManager Inc's 13F filing for Q2 2022, filed 5 Aug 2022.